Company Filing History:
Years Active: 1993-1996
Title: Jo-Ann M Jablonski: Innovator in Thrombin Inhibition
Introduction
Jo-Ann M Jablonski is a prominent inventor based in Middleborough, MA (US). She has made significant contributions to the field of biomedical engineering, particularly in the development of thrombin inhibitors. With a total of three patents to her name, her work has the potential to impact therapeutic and diagnostic applications.
Latest Patents
Her latest patents include innovative methods for coating invasive devices with inhibitors of thrombin. This invention focuses on the use of novel biologically active molecules that bind to and inhibit thrombin. The molecules are characterized by a catalytic site directed moiety (CSDM) with specific structural components that enhance their efficacy. Additionally, her work on inhibitors of thrombin also involves similar biologically active molecules designed for therapeutic, prophylactic, and diagnostic purposes.
Career Highlights
Jo-Ann M Jablonski has established herself as a key figure in her field through her innovative research and development efforts. She is currently associated with Biogen, Incorporated, where she continues to advance her work in thrombin inhibition and related biomedical applications.
Collaborations
Some of her notable coworkers include John M Maraganore and Paul R Bourdon, who have collaborated with her on various projects within the company.
Conclusion
Jo-Ann M Jablonski's contributions to thrombin inhibition represent a significant advancement in biomedical research. Her innovative patents and ongoing work at Biogen, Incorporated highlight her role as a leading inventor in this critical area of healthcare.